Alzheon…announced it will present new clinical, safety, imaging, and biomarker ﬁndings, as well as brain edema (ARIA-E) and brain microhemorrhage (ARIA-H) for its lead investigational therapy, valiltramiprosate/ALZ-801, at the American Academy of Neurology (AAN) Annual Meeting